Editas Medicine, Inc. (EDIT) Q1 2021 Earnings Call Transcript

Earlier this morning, we issued a press release providing our financial results and corporate updates for the first quarter of 2021. As a reminder, various remarks that we make during this call about the company's future expectations, plans, and prospects constitute forward-looking statements for purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Risk Factors section of our most recent annual report on Form 10-K, which is on file with the SEC.